NDC 70748-299

ATOVAQUONE

Atovaquone

ATOVAQUONE is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Atovaquone.

Product ID70748-299_26a9360d-7db4-42fe-b9d2-ecddfe369d2e
NDC70748-299
Product TypeHuman Prescription Drug
Proprietary NameATOVAQUONE
Generic NameAtovaquone
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2021-06-01
Marketing CategoryANDA /
Application NumberANDA210692
Labeler NameLupin Pharmaceuticals, Inc.
Substance NameATOVAQUONE
Active Ingredient Strength750 mg/5mL
Pharm ClassesAntimalarial [EPC],Antiprotozoal [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 70748-299-01

1 BOTTLE in 1 CARTON (70748-299-01) > 210 mL in 1 BOTTLE
Marketing Start Date2021-06-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ATOVAQUONE" or generic name "Atovaquone"

NDCBrand NameGeneric Name
0121-0888AtovaquoneAtovaquone
0121-0898AtovaquoneAtovaquone
0904-7064AtovaquoneAtovaquone
16714-900atovaquoneatovaquone
31722-629AtovaquoneAtovaquone
50268-086AtovaquoneAtovaquone
60687-534AtovaquoneAtovaquone
65162-693ATOVAQUONEATOVAQUONE
66689-062AtovaquoneAtovaquone
66993-062Atovaquoneatovaquone
68180-282AtovaquoneAtovaquone
68462-421atovaquoneatovaquone
69452-252AtovaquoneAtovaquone
70166-488AtovaquoneAtovaquone
70748-299ATOVAQUONEATOVAQUONE
10702-223Atovaquone Oral SuspensionAtovaquone
0173-0547MEPRONatovaquone
0173-0665MEPRONatovaquone

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.